The DOI matches its Crossref record; 119 of the 121 references it cites were found in a registry or an index.
Interactive Association of Drugs Binding to Human Serum Albumin
Open accessAbstract
Human serum albumin (HSA) is an abundant plasma protein, which attracts great interest in the pharmaceutical industry since it can bind a remarkable variety of drugs impacting their delivery and efficacy and ultimately altering the drug's pharmacokinetic and pharmacodynamic properties. Additionally, HSA is widely used in clinical settings as a drug delivery system due to its potential for improving targeting while decreasing the side effects of drugs. It is thus of great importance from the viewpoint of pharmaceutical sciences to clarify the structure, function, and properties of HSA-drug complexes. This review will succinctly outline the properties of binding site of drugs in IIA subdomain within the structure of HSA. We will also give an overview on the binding characterization of interactive association of drugs to human serum albumin that may potentially lead to significant clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In conjunction with an exterior aqueous environment, large proteins like HSA that have multiple hydrophobic binding sites can provide an amphiphilic environment in which different protein residues interact with the polar headgroups and hydrophobic perfluorotails of PFAS simultaneously [57].”
From In-Vitro and In-Silico Assessment of Per- and Polyfluoroalkyl Substances (PFAS) in Aqueous Film-Forming Foam (AFFF) Binding to Human Serum Albumin (2021) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,833
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Carter, D. C., & Ho, J. X. (1994) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60640-3 · Cited by 3,184
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,089
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 2,008
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
Crystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,816
The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
Sudlow, G., Birkett, D. J., & WADE, D. N. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10691-3 · Cited by 1,769
Molecular aspects of ligand binding to serum albumin.
Kragh‐Hansen, U. (1981) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06849-8 · Cited by 1,546
Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
Sudlow, G., Birkett, D. J., & WADE, D. N. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10855-9 · Cited by 1,453
Curry, S., Mandelkow, H., Brick, P., & Franks, N. P. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,378
The extraordinary ligand binding properties of human serum albumin
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., & Ascenzi, P. (2005) · IUBMB Life · doi:10.1080/15216540500404093 · Cited by 1,090
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., Yang, Y., Zhou, R., Zhao, Y., Chai, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105270108 · Cited by 938
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 925
Bhattacharya, A. A., Gruene, T., & Curry, S. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4158 · Cited by 914
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Kragh‐Hansen, U., Chuang, V. T. G., & Otagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.695 · Cited by 896
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 853
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin
Petitpas, I., Bhattacharya, A. A., Twine, S., Malcolm, E. A. S. T., & Curry, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100575200 · Cited by 827
Three-Dimensional Structure of Human Serum Albumin
Carter, D. C., He, X., Munson, S. H., Twigg, P. D., Gernert, K. M., Broom, M. B. H., & Miller, T. Y. (1989) · Science · doi:10.1126/science.2727704 · Cited by 602
Abou‐Zied, O. K., & Al-Shihi, O. I. K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8031289 · Cited by 532
Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin
Bhattacharya, A. A., Curry, S., & Franks, N. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005460200 · Cited by 529
Albumin as a versatile platform for drug half-life extension
Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 510
Crystal structural analysis of human serum albumin complexed with hemin and fatty acid
Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., & Curry, S. (2003) · BMC Structural Biology · doi:10.1186/1472-6807-3-6 · Cited by 509
Binding of transition metal ions to albumin: Sites, affinities and rates
Bal, W., Sokołowska, M., Kurowska, E., & Faller, P. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.018 · Cited by 495
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 490
Petitpas, I., Gruene, T., Bhattacharya, A. A., & Curry, S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.5208 · Cited by 487
Patel, B. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S., & Amin, A. F. (2008) · CNS Drugs · doi:10.2165/0023210-200923010-00003 · Cited by 466
Albumin–drug interaction and its clinical implication
Yamasaki, K., Chuang, V. T. G., Maruyama, T., & Otagiri, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.005 · Cited by 464
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 450
Binding of Drugs to Serum Albumin
Koch‐Weser, J., & Sellers, E. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940605 · Cited by 411
Zsila, F. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400027q · Cited by 399
Clinical impact of serum proteins on drug delivery
Kratz, F., & Elsadek, B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.028 · Cited by 377
The Binding of Drugs by Plasma Proteins
Meyer, M. C., & Guttman, D. E. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600570601 · Cited by 372
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
Jusko, W. J., & Gretch, M. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537608995839 · Cited by 372
Clinical pharmacokinetics and phamacodynamics: concepts and applications
Rowland, M., & Tozer, T. N. (2011) · Cited by 367
Bertucci, C., & Domenici, E. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369673 · Cited by 355
Simard, J. R., Zunszain, P. A., Hamilton, J. A., & Curry, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.028 · Cited by 344
Ahmad, B., Parveen, S., & Khan, R. H. (2006) · Biomacromolecules · doi:10.1021/bm050996b · Cited by 337
Binding of Drugs by Albumin Plasma Protein
Vallner, J. J. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660402 · Cited by 335
The Atomic Structure of Human Methemalbumin at 1.9 Å
Wardell, M. R., Wang, Z., Ho, J. X., Robert, J., Rüker, F., Ruble, J. R., & Carter, D. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6540 · Cited by 332
Structure of Human Serum Albumin
Carter, D. C., & He, X. (1990) · Science · doi:10.1126/science.2374930 · Cited by 320
Peters, T. (1995) · Elsevier eBooks · doi:10.1016/b978-012552110-9/50006-4 · Cited by 315
Frostell‐Karlsson, Å., Remaeus, A., Roos, H., Andersson, K., Borg, P., Hämäläinen, M., & Karlsson, R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991174y · Cited by 307
Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin
Curry, S. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.342 · Cited by 302
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Chuang, V. T. G., Kragh‐Hansen, U., & Otagiri, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1015396825274 · Cited by 299
In silico prediction of drug‐binding strengths to human serum albumin
Colmenarejo, G. (2003) · Medicinal Research Reviews · doi:10.1002/med.10039 · Cited by 292
Simard, J. R., Zunszain, P. A., Ha, C., Yang, J., Bhagavan, N. V., Petitpas, I., Curry, S., & Hamilton, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506440102 · Cited by 271
Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα
Zunszain, P. A., Ghuman, J., McDonagh, A. F., & Curry, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.016 · Cited by 267
Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia
Petitpas, I., Petersen, C. E., Ha, C., Bhattacharya, A. A., Zunszain, P. A., Ghuman, J., Bhagavan, N. V., & Curry, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1137188100 · Cited by 258
Cheminformatic Models To Predict Binding Affinities to Human Serum Albumin
Colmenarejo, G., Álvarez-Pedraglio, A. I., & Lavandera, J.-L. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010960b · Cited by 255
Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity
Watanabe, H., Tanase, S., Nakajou, K., Maruyama, T., Kragh‐Hansen, U., & Otagiri, M. (2000) · Biochemical Journal · doi:10.1042/bj3490813 · Cited by 237
Yang, F., Bian, C., Zhu, L., Zhao, G., Huang, Z., & Huang, M. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.08.015 · Cited by 228
Self-citationA Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
Otagiri, M. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.309 · Cited by 228
Interdomain zinc site on human albumin
Stewart, A. J., Blindauer, C. A., Berezenko, S., Sleep, D., & Sadler, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436576100 · Cited by 189
Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
Banks, W. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.005 · Cited by 184
Allosteric Modulation of Drug Binding to Human Serum Albumin
Ascenzi, P., Bocedi, A., Notari, S., Fanali, G., Fesce, R., & Fasano, M. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706776361448 · Cited by 174
Identification and characterization of oxidized human serum albumin
Kawakami, A., Kubota, K., Yamada, N., Tagami, U., Takehana, K., Sonaka, I., Suzuki, E., & Hirayama, K. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05341.x · Cited by 170
Kratz, F., Müller-Driver, R., Hofmann, I., Drevs, J., & Unger, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905864 · Cited by 166
Wang, Z., Ho, J. X., Ruble, J. R., Rose, J. P., Rüker, F., Ellenburg, M., Murphy, R., Click, J., Soistman, E., Wilkerson, L., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.032 · Cited by 159
Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin
Blindauer, C. A., Harvey, I., Bunyan, K. E., Stewart, A. J., Sleep, D., Harrison, D. J., Berezenko, S., & Sadler, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003459 · Cited by 157
Schönfeld, D. L., Ravelli, R. B. G., Müeller, U., & Skerra, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.020 · Cited by 155
Ryan, A. J., Ghuman, J., Zunszain, P. A., Chung, C., & Curry, S. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.10.004 · Cited by 155
Serum Proteins as Drug Carriers of Anticancer Agents: A Review
Kratz, F., & Beyer, U. (1998) · Drug Delivery · doi:10.3109/10717549809065759 · Cited by 154
Human albumin: old, new, and emerging applications
Małkowski, P. (2013) · Annals of Transplantation · doi:10.12659/aot.889188 · Cited by 150
Native albumin for targeted drug delivery
Neumann, E., Frei, E., Funk, D., Becker, M. D., Schrenk, H., Müller‐Ladner, U., & Fiehn, C. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.498474 · Cited by 147
Zhu, L., Yang, F., Chen, L., Meehan, E. J., & Huang, M. (2008) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.12.004 · Cited by 136
Self-citationKragh‐Hansen, U. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.015 · Cited by 131
Structural Mechanism of Ring-opening Reaction of Glucose by Human Serum Albumin
Wang, Y., Yu, H., Shi, X., Luo, Z., Lin, D., & Huang, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467027 · Cited by 127
Lejon, S., Frick, I.-M., Björck, L., Wikström, M., & Svensson, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406957200 · Cited by 125
Novel insights into the pleiotropic effects of human serum albumin in health and disease
Ha, C., & Bhagavan, N. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.012 · Cited by 124
Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin
Hein, K. L., Kragh‐Hansen, U., Morth, J. P., Jeppesen, M. D., Otzen, D. E., MØLLER, J. V., & Nissen, P. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.03.014 · Cited by 123
Liu, M., Lim, Z. J., Gwee, Y. Y., Levina, A., & Lay, P. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906079 · Cited by 122
Preparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate
Dosio, F., Brusa, P., Crosasso, P., Arpicco, S., & Cattel, L. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01656-8 · Cited by 115
The role of the protein-binding on the mode of drug action as well the interactions with other drugs
Tesseromatis, C., & Alevizou, A. (2008) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190876 · Cited by 110
Molecular Interaction Studies of Trimethoxy Flavone with Human Serum Albumin
Gokara, M., Sudhamalla, B., Damu, A. G., & Subramanyam, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008834 · Cited by 108
The Blood–Brain Barrier in Alzheimer's Disease
Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 105
Proteins: emerging carrier for delivery of cancer therapeutics
Yewale, C. R., Baradia, D., Vhora, I., & Misra, A. R. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.805200 · Cited by 94
Virus Trap in Human Serum Albumin Nanotube
Komatsu, T., Qu, X., Ihara, H., Fujihara, M., Azuma, H., & Ikeda, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1096122 · Cited by 91
Structural Evidence of Perfluorooctane Sulfonate Transport by Human Serum Albumin
Luo, Z., Shi, X., Hu, Q., Zhao, B., & Huang, M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300112p · Cited by 90
A spectroscopic study of the interaction of isoflavones with human serum albumin
Gangadhariah, M. H., Singh, S. A., Srinivasan, N., & Rao, A. G. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05071.x · Cited by 90
Rational Design of Diflunisal Analogues with Reduced Affinity for Human Serum Albumin
Mao, H., Hajduk, P. J., Craig, R., Bell, R., Borre, T., & Fesik, S. W. (2001) · Journal of the American Chemical Society · doi:10.1021/ja015955b · Cited by 87
Molecular Capture in Protein Nanotubes
Qu, X., & Komatsu, T. (2009) · ACS Nano · doi:10.1021/nn901474y · Cited by 85
Buttar, D., Colclough, N., Gerhardt, S., MacFaul, P. A., Phillips, S. D., Plowright, A. T., Whittamore, P. R. O., Tam, K. Y., Maskos, K., Steinbacher, S., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.052 · Cited by 85
Location and characterization of the warfarin binding site of human serum albumin
Bos, O. J. M., Remijn, J. P. M., Fischer, M. J. E., Wilting, J., & Janssen, L. H. M. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90072-x · Cited by 83
Elucidation of the Binding Mechanism of Coumarin Derivatives with Human Serum Albumin
Garg, A., Manidhar, D. M., Gokara, M., Malleda, C., Reddy, C. S., & Subramanyam, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063805 · Cited by 77
Komatsu, T., Wang, R., Zunszain, P. A., Curry, S., & Tsuchida, E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0656806 · Cited by 76
Temperature-Dependent Simultaneous Ligand Binding in Human Serum Albumin
Sinha, S. S., Mitra, R. K., & Pal, S. K. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp709809b · Cited by 73
Studies on the interaction between Ag+ and human serum albumin
Shen, X., Liang, H., Guo, J., Song, C., He, X., & Yuan, Y.-Z. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00094-1 · Cited by 72
Self-citationSon, S., Song, S.-Y., Lee, S. J., Min, S., Kim, S. A., Yhee, J. Y., Huh, M. S., Kwon, I. C., Jeong, S. Y., Byun, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.085 · Cited by 71
Exploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Modi, S., Jain, J. P., Domb, A. J., & Kumar, N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026272 · Cited by 69
The subsequent effect of interaction between Co2+ and human serum albumin or bovine serum albumin
Liang, H., Huang, J. L., Tu, C., Zhang, M., Zhou, Y., & Shen, P. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00195-7 · Cited by 67
Self-citationYamaguchi, S., Aldini, G., Ito, S., Morishita, N., Shibata, T., Vistoli, G., Carini, M., & Uchida, K. (2009) · Journal of the American Chemical Society · doi:10.1021/ja908878n · Cited by 67
Lejon, S., Cramer, J. F., & Nordberg, P. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s174430910706770x · Cited by 63
Interactive Associations of Drug–Drug and Drug–Drug–Drug with IIA Subdomain of Human Serum Albumin
Yang, F., Yue, J., Ma, L., Ma, Z., Li, M., Wu, X., & Liang, H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300322y · Cited by 56
Self-citationBos, O. J. M., Fischer, M. J. E., Wilting, J., & Janssen, L. H. M. (1988) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(88)90007-6 · Cited by 55
Brain Delivery of Biotin Bound to a Conjugate of Neutral Avidin and Cationized Human Albumin
Kang, Y., & Pardridge, W. M. (1994) · Pharmaceutical Research · doi:10.1023/a:1018982125649 · Cited by 48
Study on Binding of Drug to Serum Protein
Otagiri, M. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.413 · Cited by 47
Epitope Mapping and Competitive Binding of HSA Drug Site II Ligands by NMR Diffusion Measurements
Lucas, L. H., Price, K. E., & Larive, C. K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0479538 · Cited by 46
Structural basis of transport of lysophospholipids by human serum albumin
Guo, S., Shi, X., Yang, F., Chen, L., Meehan, E. J., Bian, C., & Huang, M. (2009) · Biochemical Journal · doi:10.1042/bj20090913 · Cited by 46
Self-citationIn silicoprediction of human serum albumin binding for drug leads
Vallianatou, T., Lambrinidis, G., & Tsantili‐Kakoulidou, A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.777424 · Cited by 41
Dioxygenation of Human Serum Albumin Having a Prosthetic Heme Group in a Tailor-Made Heme Pocket
Komatsu, T., Ohmichi, N., Zunszain, P. A., Curry, S., & Tsuchida, E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja046022t · Cited by 40
Ryan, A. J., Chung, C., & Curry, S. (2011) · BMC Structural Biology · doi:10.1186/1472-6807-11-18 · Cited by 38
Ascoli, G. A., Bertucci, C., & Salvadori, P. A. (1998) · Biomedical Chromatography · doi:10.1002/(sici)1099-0801(199809/10)12:5 · Cited by 37
Albumin reduces thrombogenic potential of single-walled carbon nanotubes
Vakhrusheva, T. V., Gusev, A. A., Гусев, С. А., & Vlasova, I. I. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.05.642 · Cited by 32
Ehrlich, G. K., Michel, H., Truitt, T., Riboulet, W., Pop-Damkov, P., Goelzer, P., Hainzl, D., Qureshi, F., Lueckel, B., Danho, W., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400340z · Cited by 29
Silva, D., Cortez, C. M., Silva, C. M. C., & Missailidis, S. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.06.015 · Cited by 24
The influence of binding to albumin and α1-acid glycoprotein on the clearance of drugs by the liver
Meijer, D., & van der Sluijs, P. (1987) · Pharmaceutisch Weekblad · doi:10.1007/bf01960738 · Cited by 22
Human serum albumin-based design of a diflunisal prodrug
Yang, F., Yuan, Z., Zhang, Y., Li, G. Q., Li, M., Qin, J., Lockridge, O., & Liang, H. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.013 · Cited by 22
Self-citationWang, Y., Luo, Z., Shi, X., Wang, H., Nie, L., & Huang, M. (2011) · Protein Science · doi:10.1002/pro.749 · Cited by 20
Komatsu, T., Nakagawa, A., & Qu, X. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.287 · Cited by 18
Yang, F., Lee, P., Ma, Z., Ma, L., Yang, G., Wu, X., & Liang, H. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23336 · Cited by 14
Self-citationComparison of Binding Characterization of Two Antiviral Drugs to Human Serum Albumin
Li, M., McAuley, E. M., Zhang, Y., Kong, L., Yang, F., Zhou, Z., Wu, X., & Liang, H. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12270 · Cited by 13
Self-citation[Blood-brain barrier and Alzheimer's disease].
Kuwahara, H., Nishida, Y., & Yokota, T. (2013) · PubMed · Cited by 12
Hsa-Based Anti-Inflammatory Therapy: A New and Improved Approach
Liang, H., Yang, F., Lee, N., & Wu, X. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.195 · Cited by 10
Self-citationX‐ray Crystallographic and Fluorometric Analysis of the Interactions of Rhein to Human Serum Albumin
Li, M., Lee, P., Zhang, Y., Ma, Z., Yang, F., Zhou, Z., Wu, X., & Liang, H. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12208 · Cited by 6
Self-citationTillement, J. P., Duché, J.-C., & Barré, J. (2006) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33276-5 · Cited by 6
Transferrin-coated gadolinium-labeled human serum albumin nanoparticles
Chopra, A. (2013) · Europe PMC (PubMed Central) · Cited by 2
Flagged first, then by citations
2 of the 121 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Tillement, 2006, Drug binding to blood proteins: Characteristics roles and pathophysiological changes, Bull. Acad. Natl. Med., 190, 935
Cited by
Sorted by citations
Lomis, N., Westfall, S., Farahdel, L., Malhotra, M., Shum‐Tim, D., & Prakash, S. (2016) · Nanomaterials · doi:10.3390/nano6060116 · Cited by 188
Targeted Delivery Methods for Anticancer Drugs
Veselov, V. V., Nosyrev, A. E., Jicsinszky, L., Alyautdin, R. N., & Cravotto, G. (2022) · Cancers · doi:10.3390/cancers14030622 · Cited by 184
Studying the interaction of drug/ligand with serum albumin
Siddiqui, S., Ameen, F., Rehman, S. U., Sarwar, T., & Tabish, M. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116200 · Cited by 173
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin
Al-Harthi, S., Lachowicz, J. I., Nowakowski, M. E., Jaremko, M., & Jaremko, Ł. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110716 · Cited by 156
Metadata
- Authors
- Yang, F., Zhang, Y., & Liang, H.
- Affiliations
- Guangxi Normal University (CN)
- Corresponding author
- Yang, Feng
- Liang, Hong
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-02-27
- Volume
- 15
- Issue
- 3
- Pages
- 3580-3595
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC3975355
- OpenAlex
- W1973788406
- Cited by
- 376
- References
- 121
- Citations by year
- 2026: 26 · 2025: 40 · 2024: 38 · 2023: 33 · 2022: 48 · 2021: 26 · 2020: 35 · 2019: 38 · 2018: 24 · 2017: 25 · 2016: 29 · 2015: 14
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31060121, 20130403-1, 21171043, 2013GXNSFGA019010)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- human serum albumin, drug binding, binding sites, drug delivery systems, pharmacokinetics, pharmacodynamics
- MeSH terms
- Binding Sites, Pharmaceutical Preparations, Humans, Kinetics, Models, Molecular, Protein Binding, Serum Albumin, Molecular Structure, Protein Structure, Secondary, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review